Fatigue News and Research

RSS

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

Sexuality essentially silenced following stroke

Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

6 Sep 2018

Low-income Californians feel twice the burn from wildfires

Viviana Aguirre, 14, knows the air is bad when she has to reach for her inhaler once, maybe twice a week.

4 Sep 2018

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

30 Aug 2018

Ultralaser treatment reduces pain in patients with fibromyalgia

A new device that combines low-intensity laser light and therapeutic ultrasound considerably reduces the pain experienced by patients with fibromyalgia.

30 Aug 2018

'Mystery illness' afflicting diplomats linked to RF/MW radiation

Writing in advance of the September 15 issue of Neural Computation, Beatrice Golomb, MD, PhD, professor of medicine at University of California San Diego School of Medicine, says publicly reported symptoms and experiences of a "mystery illness" afflicting American and Canadian diplomats in Cuba and China strongly match known effects of pulsed radiofrequency/microwave electromagnetic radiation.

30 Aug 2018

Novel program offers new options for adult congenital heart patients

Experts at the Vanderbilt Heart and Vascular Institute are forging new ground in the development of a first-of-its-kind program aimed at adults with congenital heart disease.

29 Aug 2018

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Johns Hopkins Medicine researchers say new experiments using magnetic pulse brain stimulation on people with moderate to severe restless legs syndrome have added to evidence that the condition is due to excitability and hyperarousal in the part of the brain's motor cortex responsible for leg movement.

29 Aug 2018

Study explores whether chemotherapy affects older woman's ability to function

Older women are at higher risk for developing breast cancer than younger women are--almost half of all breast cancer cases, and most breast cancer deaths, occur in women who are 65 or older. Despite this, we know very little about how breast cancer and its treatments affect older women.

29 Aug 2018

Patients and families gather to gain more awareness, knowledge about myositis

In early 2015, Mike Matthews, a teacher, social worker, and counselor for the State of Kentucky, experienced a constellation of apparently unrelated health problems that doctors could not diagnose. He lost more than thirty pounds, had trouble swallowing and speaking, developed a rash over his knuckles and other parts of his body, and experienced extreme muscle weakness and fatigue.

29 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

New smartphone app can help detect atrial fibrillation

A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.

28 Aug 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

Study demonstrates cardiovascular safety of weight loss drug

A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal of Medicine.

27 Aug 2018

Weight loss pill Lorcaserin found to have low cardiovascular risk

Weight loss pills have been discovered and then withdrawn from the market because of the risks that they pose to the heart. Some of them have raised the risk of heart attacks, suicides, heart valve problems significantly and have been thus banned.

27 Aug 2018

A late-life surprise: Taking care of frail, aging parents

"This won't go on for very long," Sharon Hall said to herself when she invited her elderly mother, who'd suffered several small strokes, to live with her.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Common ADHD drug may cause adverse psychotic side effects

In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.

22 Aug 2018

Standard hypothyroidism treatment inadequate in controlling crucial aspects of the condition

What if the standard treatment for hypothyroidism--insufficient thyroid hormone--is inadequate in controlling some crucial aspects of the condition? That's the provocative question asked, and answered affirmatively with objective data, in a study led by a Rush researcher presented this week in The Journal of Clinical Endocrinology & Metabolism.

22 Aug 2018

New research finds significant link between high Omega-3 Index and depression

New research published in the August edition of the Journal of the American College of Cardiology's Heart Failure issue found significant correlations between blood levels of EPA plus DHA omega-3s in "cognitive" depression among heart failure subjects.

22 Aug 2018